Purpose: We have developed an animal model of Peyronie's disease by injecti
ng transforming growth factor beta (TGF-beta) into the rat penis. Our objec
tive is to study the effects of colchicine on the Peyronie's condition in a
n animal model.
Materials and Methods: Thirty six adult male Sprague-Dawley rats received T
GF-beta injections into the tunica albuginea and were divided into two grou
ps (n = 18 each). Rats in the first group were divided into three subgroups
(n = 6 each).
Each rat in the three subgroups received the following: Subgroup 1 received
colchicine, subgroup 2 received ibuprofen, and subgroup 3 received regular
water. The rats were euthanized after 6 weeks, Rats in the second group we
re also divided into three subgroups. These rats received the same treatmen
ts as the rats in the first group, but treatments began 6 weeks after TGF-b
eta injection. These rats were cuthanized after 12 weeks. Tunical tissue sa
mples were collected and examined using Hart and trichrome stains, electron
microscopy (EM), and western blot analysis for TGF-beta detection.
Results: In the first group, the colchicine-treated rats exhibited less col
lagen deposition and less elastic fiber fragmentation than the untreated or
ibuprofen-treated rats. EM confirmed the results and showed normal distrib
ution and shape of both collagen and elastic fibers in the colchicine-treat
ed group. In the second group, the colchicine-treated rats exhibited less c
rowding of the collagen fibers. However, the elastic fibers remained fragme
nted and scarce. Western blot analysis showed significant down-regulation o
f TGF-beta expression (5/6) in the colchicine-treated group after 6 weeks.
Down-regulation was observed in only 1/6 in both ibuprofen and nontreated g
roups. After 12 weeks 2/6, 1/6, and 1/6 rats displayed down regulation in t
he colchicine treated, ibuprofen treated, and non-treated groups, respectiv
ely.
Conclusion: Early colchicine treatment may suppress a Peyronie's like condi
tion in the rat animal model.